Real Brands Inc. (OTCQB:RLBD) has signed the definitive agreement for the acquisition of substantially all the assets of Boulder Botanical & Biosciences Laboratories, Inc., a manufacturer of white-label and private-label wellness and sports medicine herbal supplements and CBD products, from Frankens Investment Fund, LLC, which had acquired Boulder Botanical in April 2022. The acquisition will include Boulder Botanical’s brands for human and pet markets, IP, and distribution at the 27,000 sq. ft. R&D and production facility in Golden, Colorado. The value of the transaction is $12 million, with a $1 million operating capital commitment. Boulder Botanical will retain its name and operate as a division of Real Brands.
Thom Kidrin, president & CEO of Real Brands Inc., stated, “Boulder Botanical has had an excellent reputation for creating quality sports medicine, health and wellness herbal supplements and cannabinoid formulations and its white-label manufacturing services exceeding industry standards. We expect to build upon that solid foundation. Boulder Botanical’s existing national distribution network serving CVS, Target, Costco, and other retailers, combined with Real Brands’ expertise in online sales and the metaverse, enables ready access to millions of existing customers and millions more potential customers online and in person. With this acquisition, we have increased our production capacity by 300%, have added a portfolio of 150+ brands, extensive IP, and a skilled R&D team to create hundreds more products to meet the demand of the burgeoning herbal supplement and CBD markets.”
